Ecolex Logo
Le portail au
droit de l'environnement
Résultats de la recherche » Législation

Governmental Decree No. 867 validating “Licensing procedures for the production of medicines, pharmacy practices, medical care and services, as well as curricula for secondary and higher medical education and approval of the form of licenses in the specified areas of professional activity”.

Pays/Territoire
Arménie
Type du document
Règlement
Date
2002 (2013)
Source
FAO, FAOLEX
Sujet
Bétail
Mot clé
Santé des animaux Médicaments Commerce/industrie/sociétés Autorisation/permis Recherche Mise en application Collecte de données/déclarations Accès-à-l'information
Aire géographique
Asie, CEI (Communauté des États indépendants), Europe, Europe et Asie Centrale, Nations en développement sans littoral, Asie Occidentale
Entry into force notes
This Governmental Decree enters into force on 15 January 2013.
Résumé

This Governmental Decree establishes “Licensing procedures for the production of medicines, pharmacy practices, medical care and services, as well as curricula for secondary and higher medical education and approval of the form of licenses in the specified areas of professional activity”. It defines the main technological processes for the manufacturing of high quality drugs, describes manufacturing technical equipment, sets forth the structure of manufacturing operational units and establishes guidelines for quality assessment of drugs. It also defines pharmacy and medical care practices applicable to humans and animals, and to research purposes, and imposes mandatory licensing of drug manufacturing. Serial drug production includes the following processes: (a) purchase of starting materials; (b) production technological processes; (c) quality assessment and control; (d) packaging (re-packaging); (e) labelling; and (f) storage. License shall be issued for at least one production processes, except for separate activities, such as purchase of starting materials, storage and quality assessment. License shall be issued by licensing authority within 30 days from the date of filing the application and it shall be based on expert opinion. The applicant must submit application in accordance with the forms contained in the Annexes 1 and 2, identification data for legal entities and individual entrepreneurs, information in accordance with the list contained in the Annex 3 and the list of available technical and technological equipment in accordance with the Annex 5. Drug manufacturers must use only authorized active pharmaceutical ingredients in accordance with applicable production rules. Manufactured drugs must comply with the established quality requirements, while non-complying drugs shall be subject to recycling and destruction.

Texte intégral
Arménien
Site web
www.arlis.am